Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil Dose Response in PAH
NCT00430716Phase 4Terminated
- Sponsor
- Viatris
- Start
- Apr 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 4 trial of ASP-001 in pulmonary arterial hypertension (PAH), sponsored by Viatris. Started Apr 2008; status: terminated.
02
Drugs
ASP-001
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00430716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430716.